<DOC>
	<DOCNO>NCT02528994</DOCNO>
	<brief_summary>This study test effect short-term , high-dose dietary serine supplementation circulating level serine . Individuals risk factor type 2 diabetes recruit 2 week study . Effects dietary serine supplementation glycemic measure also explore .</brief_summary>
	<brief_title>Short Term Dietary Serine Supplementation Circulating Serine Levels</brief_title>
	<detailed_description>This single-center , open-label , randomize , nutritional intervention study adult . Subjects three visit Massachusetts General Hospital Clinical Research Center ( CRC ) 2 week study . At first study visit ( Visit 1 ) , follow occur : informed consent ; medical nutritional history assessment ; blood pressure , weight height , fast blood draw blood work 2 hr oral glucose tolerance test ; explanation instruction completion 4-day food log ; randomize assignment dose dietary serine supplementation ( 6g , 12g , 24g , 48g ) ; provide 7 day dietary serine supplement ; take first dose supplement snack ; schedule Visit 2 Visit 3 . Between Visit 1 Visit 2 , participant complete Food Log take assign dose dietary serine supplementation 3 time daily . Visit 2 occur 7 day Visit 1 . Subjects take dietary serine supplementation prior Visit 2 activity . At Visit 2 , follow occur : weight blood pressure ; fast blood draw ; administration assign dose dietary serine supplementation snack blood work ; review 4-day food log ; provide 7 day dietary serine supplement completion anonymous survey ass tolerability supplement . Participants continue take assign dose dietary serine supplementation 3 time daily Visit 2 Visit 3 . Visit 3 occur 7 day Visit 2 . At Visit 3 , follow occur : weight blood pressure ; review 4-day food log ; fast blood draw blood work 2 hr oral glucose tolerance test ; completion study survey assess tolerability supplement .</detailed_description>
	<criteria>risk factor type 2 diabetes know type 2 diabetes woman pregnant , nursing , use contraception abstinence take amino acid supplement study time 1 month prior enrollment study condition cause intestinal malabsorption , include celiac disease history intestinal gastric bypass surgery know active liver disease currently take intend take study duration medication know affect glycemic parameter , glucocorticoid , growth hormone , fluoroquinolones participation interventional study study duration inability adhere study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Dietary supplement</keyword>
	<keyword>Metabolism</keyword>
</DOC>